Cargando…
Adherence to the dietary approaches to stop hypertension diet and all-cause mortality in patients with a history of heart failure
BACKGROUND AND AIMS: We investigated the association of adherence to the Dietary Approaches to Stop Hypertension (DASH) diet with all-cause mortality in patients with a history of heart failure. METHODS: We analyzed data from the National Health and Nutrition Examination Survey (NHANES). Dietary inf...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551459/ https://www.ncbi.nlm.nih.gov/pubmed/36238461 http://dx.doi.org/10.3389/fnut.2022.1015290 |
Sumario: | BACKGROUND AND AIMS: We investigated the association of adherence to the Dietary Approaches to Stop Hypertension (DASH) diet with all-cause mortality in patients with a history of heart failure. METHODS: We analyzed data from the National Health and Nutrition Examination Survey (NHANES). Dietary information was obtained from a 24-h dietary recall interview. Adherence to the DASH diet was assessed using the DASH score. The primary outcome was all-cause mortality which was confirmed by the end of 2011. Weighted Cox proportional hazards regression models were used to determine the hazard ratios and 95% CI for the association of the DASH score and all-cause mortality with multivariate adjustment. RESULTS: The median DASH score was 2 among the 832 study participants. There were 319 participants who died after a median follow-up duration of 4.7 years. A higher DASH score (>2 vs. ≤ 2) was not associated with a decrease in the risk of all-cause mortality (adjusted HR 1.003, 95% CI 0.760–1.323, p = 0.983). With respect to the components of the DASH score, a lower sodium intake was not associated with a decreased risk of mortality (adjusted HR 1.045, 95% CI 0.738–1.478, p = 0.803). CONCLUSION: A higher DASH score (>2 vs. ≤ 2) was not associated with all-cause mortality in patients with heart failure. |
---|